# A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

> **NCT01053663** · PHASE1 · TERMINATED · sponsor: **Hoffmann-La Roche** · enrollment: 9 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Tamiflu

## Key facts

- **NCT ID:** NCT01053663
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** The study was terminated prematurely after three influenza seasons.
- **Last updated:** 2016-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01053663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01053663, "A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT01053663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*